Molecular Neurolmaging — New Haven, Connecticut

Molecular Neurolmaging is a clinical research site located in New Haven, Connecticut, United States 06510.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Molecular Neurolmaging has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Parkinson's Disease.

Sponsors: Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Molecular Neurolmaging?

Molecular Neurolmaging has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Molecular Neurolmaging conducted?

Molecular Neurolmaging has 1 clinical trials on record, with 1 currently active. Their work covers Parkinson's Disease.

Is Molecular Neurolmaging accredited by Crixeo Health?

Molecular Neurolmaging has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Molecular Neurolmaging?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.